These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8009937)
1. [The effect of dalargin on the opioid and immune systems in patients with a depressive syndrome]. Zozulia AA; Shchurin MR; Dikaia VI; Bondar' VV; Krym NM; Panteleeva GP Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):61-5. PubMed ID: 8009937 [TBL] [Abstract][Full Text] [Related]
2. [The effect of dalargin and des-Tyr-dalargin on the functional state of intact and ischemized-reperfused myocardium]. Lasukova TV; Maslov LN; Lishmanov IuB; Ovchinnikov MV; Bespalova ZhD; Podoksenov IuK; Podoksenov AIu Eksp Klin Farmakol; 2004; 67(4):21-5. PubMed ID: 15500040 [TBL] [Abstract][Full Text] [Related]
3. [Effect of the synthetic endogenous opioid analog dalargin on the natural cytotoxicity of human lymphocytes]. Aleksandrova EN; Nasonov EL; Vinogradov VA; Titov MI Biull Eksp Biol Med; 1988 Apr; 105(4):442-5. PubMed ID: 3359025 [TBL] [Abstract][Full Text] [Related]
4. [Proof of stimulating effect of dalargin of the process of cell division through opiate receptors]. Pan'kova TD; Timoshin SS Biull Eksp Biol Med; 1990 Jul; 110(7):96-8. PubMed ID: 2171699 [TBL] [Abstract][Full Text] [Related]
5. [The normalizing effect of dalargin on the glucocorticoid and opioid levels of the blood in CBA and C57Bl/6 mice undergoing footshock stress]. Shchurin MR; Pshenichkin SF; Solov'eva MS; Smirnova GV; Goncharov NP; Mit'kin VV; Sukhikh GT; Lavrov VF; Kirillicheva GB; Zozulia AA Biull Eksp Biol Med; 1992 Dec; 114(12):617-9. PubMed ID: 1292691 [TBL] [Abstract][Full Text] [Related]
6. [The effect of the synthetic leu-enkephalin analog dalargin on the proliferative activity of glioma C6 cells and on the intensity of their DNA synthesis]. Slepko NG; Kozlova MV Tsitologiia; 1992; 34(1):66-73. PubMed ID: 1636213 [TBL] [Abstract][Full Text] [Related]
7. [Radioimmunologic and radioreceptor studies of the pharmacokinetics of the enkephalin analog dalargin in man]. Zaĭtsev SV; Vinogradov VA; Sergeeva MG; Dmitrieva OF; Ivanikov IO Biull Eksp Biol Med; 1986 Jun; 101(6):702-4. PubMed ID: 3730557 [TBL] [Abstract][Full Text] [Related]
9. [Importance of opiate receptor ligands in regulating lymphocyte proliferative activity]. Zozulia AA; Voronkova TL; Patsakova E; Ivanushkin AM Farmakol Toksikol; 1987; 50(3):58-9. PubMed ID: 3038604 [TBL] [Abstract][Full Text] [Related]
10. [The growth stimulation of a cell culture of dissociated rat embryonic spinal cord under the influence of the opioid peptide dalargin and the opioid receptor blocker naloxone]. Kalenchuk VU Tsitologiia; 1993; 35(9):66-8. PubMed ID: 8266584 [TBL] [Abstract][Full Text] [Related]
11. [Effects of dalargin on proliferative processes and vertical migration of cells of the corneal epithelium during stress]. Timoshin SS; Berezhnova NI; Shvets SI Biull Eksp Biol Med; 1990 Feb; 109(2):189-91. PubMed ID: 2337661 [TBL] [Abstract][Full Text] [Related]
12. Nephroprotective effect of GSK-3β inhibition by lithium ions and δ-opioid receptor agonist dalargin on gentamicin-induced nephrotoxicity. Plotnikov EY; Grebenchikov OA; Babenko VA; Pevzner IB; Zorova LD; Likhvantsev VV; Zorov DB Toxicol Lett; 2013 Jul; 220(3):303-8. PubMed ID: 23651617 [TBL] [Abstract][Full Text] [Related]
13. [The effect of endogenous opioid peptides and their synthetic analogs on the activity of natural killer cells]. Uteshev BS; Korostelev SA; Isakova KL; Shchegolev AI Eksp Klin Farmakol; 1994; 57(1):55-7. PubMed ID: 8142867 [TBL] [Abstract][Full Text] [Related]
14. [Use of dalargin in the intensive therapy of critical conditions]. Smirnova VI; Pulina NN; Kazennov VV; Oranskiĭ AV; Smirnov EP Vestn Ross Akad Med Nauk; 1994; (6):48-51. PubMed ID: 7522704 [TBL] [Abstract][Full Text] [Related]
15. [A clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes in the maxillofacial area]. Bazhanov NN; Ganina SS; Ragimov ChR; Pashutin SB; Brusina LI Stomatologiia (Mosk); 1993; 72(4):22-5. PubMed ID: 8108814 [TBL] [Abstract][Full Text] [Related]
16. [Effect of exposure to various concentrations of dalargin on immunocompetent cells in vitro and the feasibility of its use as an immunomodulator]. Mikhu IIa; Izachik IuA; Ruzhitskaia EA; Kapustin AV Klin Lab Diagn; 1994; (1):9-10. PubMed ID: 8032743 [TBL] [Abstract][Full Text] [Related]
17. [The effect of endogenous opioid peptides and their synthetic analogs on T-cell immunity]. Korostelev SA; Isakova KL; Shchegolev AI; Uteshev BS Eksp Klin Farmakol; 1994; 57(1):57-61. PubMed ID: 8142868 [TBL] [Abstract][Full Text] [Related]
18. [Effect of peripheral opiate receptor agonist dalargin on exercise tolerance in patients with coronary and peripheral arteries atherosclerosis]. Maslov LN; Fedorova NA; Dudko VA; Karpov RS Fiziol Cheloveka; 2002; 28(5):81-7. PubMed ID: 12397935 [No Abstract] [Full Text] [Related]
19. [The effect of methionine enkephalin, leucine enkephalin and the hexapeptide, dalargin on the morphology of cultured neurons]. Lindner G; Grosse G; Wenzel M; Jentzsch KD; Forner K; Oehme P J Hirnforsch; 1988; 29(5):547-56. PubMed ID: 3216101 [TBL] [Abstract][Full Text] [Related]
20. [The restriction of hemodynamic disorders in acute hypoxia and in situ reoxygenation by using the synthetic peptide bioregulator dalargin]. Pashutin SB Biull Eksp Biol Med; 1991 Nov; 112(11):505-7. PubMed ID: 1810489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]